Please assess the completion status of the following clinical trial:

Trial Title: Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age between 45 and 75 years~* Diagnosis of diabetes mellitus made within the two years preceding the date of observation (new onset diabetes)~* Adherence to the study documented the voluntary signing of an informed consent~* Availability to follow a telephone follow-up~Exclusion Criteria:~* Remote medical history (\> 2 years) positive for diabetes mellitus~* Previous history of malignancy~* Pregnancy~* Renal Failure~* Documented diabetic microangiopathy~* Sepsis

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- High AM (Type: None): Newly diagnosed diabetic patients with high Adrenomedullin serum levels
- Low AM (Type: None): Newly diagnosed diabetic patients with low Adrenomedullin serum levels

Based on this trial design, predict the completion outcome and termination type (if applicable).